Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Travis Abicht

Thoracic Surgery (Cardiothoracic Vascular Surgery) Missoula, MT Medical Doctor

NPI 1033239835 CMS profile 47186

500 W Broadway St, Ste 320, Missoula, MT 59802

Open in the dashboard

General payments

$39,139

109 records reported · program years 2019–2025

Research payments

$263

Paid to them · 3 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$170,083 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Travis Abicht of Missoula, MT is reported in the CMS Open Payments database as having received $39,139 across 109 general payments and $263 in research payments paid to them. Separately, studies naming them as principal investigator received $170,083 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 87th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $581 11
2024 General $1,581 12
2023 General $1,902 10
2023 Research $263 3
2022 General $1,647 8
2021 General $7,689 17
2020 General $6,459 19
2019 General $19,281 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Travis Abicht
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Travis Abicht were reported at $581. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Travis Abicht Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $19,281 $886 $178–$3,167 $163
2020 $6,459 $341 $108–$1,605 $114
2021 $7,689 $453 $125–$1,886 $132
2022 $1,647 $695 $180–$2,566 $149
2023 $1,902 $745 $205–$2,662 $160
2024 $1,581 $799 $214–$2,967 $164
2025 $581 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $29,191 46 payments
  2. Medtronic, Inc. $7,169 36 payments
  3. Abiomed $1,571 4 payments
  4. Medtronic Vascular, Inc. $1,189 22 payments
  5. CryoLife, Inc. $20 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $27,208 16 payments
  2. Food and Beverage $4,047 78 payments
  3. Travel and Lodging $4,045 13 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,840 2 payments
Products named General payments · program years 2019–2025
  1. CardioMEMS HF System $12,525 9 payments
  2. HeartMate 3 Left Ventricular Dev $11,152 12 payments
  3. HeartMate 3 Left Ventricular Assist Device Heart failure $2,494 4 payments
  4. THORATEC HEARTMATE 3 LVAS IMPLANT KIT $1,632 7 payments
  5. Impella $1,571 4 payments
  6. COREVALVE EVOLUT R $1,452 16 payments
  7. HeartWare HVAD Ventricular Assist Devices $768 17 payments
  8. HeartMate 3 Left Ventricular Assist Device Heart failure $600 3 payments
  9. Arctic Front $583 4 payments
  10. HeartWare HVAD Ventricular Assist Devices $426 6 payments
  11. Other $1,570 22 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Abiomed $263 3 payments

Billing to Medicare

Part B · data year 2024 · 52 billing codes

Paid by Medicare

$235,504

Medicare's payments for the services billed

Medicare patients

260

Average age 77

Services billed

529

98 women, 162 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 55%
Arthritis 44%
Atrial fibrillation 42%
Diabetes 32%
Chronic kidney disease 29%
Cancer 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

112 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record